MDMA PTSD Treatment Soundly Rejected by FDA Advisory Committee

Members of the FDA’s Psychopharmacological Drugs Advisory Committee voted strongly against recommending MDMA, also known as “ecstasy,” as a potential treatment for post-traumatic stress disorder (PTSD) at their meeting on Tuesday.
Source: Drug Industry Daily